Establishment Labs Holdings Inc (ESTA) News & EventsESTAEstablishment Labs Holdings Inc

Establishment Labs Presents New Data on Breast Tissue Preservation

Establishment Labs Holdings announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its Minimally Invasive Platform. Establishment Labs also announced the product line extensions of both Mia and Preserve with new sizes and supporting tools. The announcements took place during the 11th World Symposium on Ergonomic Implants, in Istanbul, Turkey. WSEI brought together over 1,000 plastic surgeons from 57 countries and featured 127 individual scientific presentations and educational sessions, highlighting advances in breast aesthetics, reconstruction, minimally invasive techniques, and the science of breast tissue preservation. Among the data presented at WSEI were findings from the recently published Breast Tissue Preservation Building Blocks Supplement in the Aesthetic Surgery Journal, a four-part, peer-reviewed publication bringing together more than 25 authors from around the world, including board-certified plastic and reconstructive surgeons, anatomists, pathologists, and researchers from leading academic and surgical institutions. Throughout the event, the lead authors presented their research findings on breast anatomy and the foundations of tissue preservation, the scientific rationale, as well as early- and mid-term clinical data on the Minimally Invasive Platform, including a review of the first published U.S. multicenter clinical experience with Preserve.The Breast Tissue Preservation supplement is a multidisciplinary effort to establish the anatomical, scientific and clinical foundations that allow for minimally invasive options. The research included is intended to provide surgeons with a standardized scientific framework for techniques designed to preserve breast anatomy while minimizing tissue disruption.

Establishment Labs Appoints Taylor Harris to Board of Directors

Establishment Labs announced the appointment of Taylor Harris to its Board of Directors. Most recently, Harris served as Chief Executive Officer of Cutera.

Company Expects Minimally Invasive Business to Exceed $35M in 2026

Consensus $264.99M. The company said, "Minimally invasive business to exceed $35 million in 2026 up from the previous guidance of $30 million; Gross margin: 71.2% to 72.2%; Operating expenses: $195 million to $200 million; Adjusted EBITDA: Positive every quarter; Free cash flow positive in the second half of the year."